Yulong Shang

2.3k total citations
55 papers, 1.8k citations indexed

About

Yulong Shang is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Yulong Shang has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Epidemiology and 16 papers in Cancer Research. Recurrent topics in Yulong Shang's work include Liver Diseases and Immunity (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Pediatric Hepatobiliary Diseases and Treatments (9 papers). Yulong Shang is often cited by papers focused on Liver Diseases and Immunity (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Pediatric Hepatobiliary Diseases and Treatments (9 papers). Yulong Shang collaborates with scholars based in China, United States and Hong Kong. Yulong Shang's co-authors include Daiming Fan, Yongzhan Nie, Kaichun Wu, Jiaqiang Dong, Bin Feng, Xiqiang Cai, Jie Liang, Gui Ren, Z Zhang and Lin Zhou and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yulong Shang

51 papers receiving 1.7k citations

Peers

Countries citing papers authored by Yulong Shang

Since Specialization

Citations

This map shows the geographic impact of Yulong Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulong Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulong Shang more than expected).

Fields of papers citing papers by Yulong Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulong Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulong Shang. The network helps show where Yulong Shang may publish in the future.

Co-authorship network of co-authors of Yulong Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Yulong Shang. A scholar is included among the top collaborators of Yulong Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulong Shang. Yulong Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine 2025 ·Clinical Reviews in Allergy & Immunology ·(unknown), Yansheng Liu, (unknown), (unknown), Changcun Guo, Patrick S.C. Leung, (unknown), M. Eric Gershwin, Yulong Shang, Ying Han	0
2	Hepatocyte-like cells and liver organoids: the application of iPSCs and their derivants for treating liver diseases 2024 ·Materials Advances ·(unknown), Siyuan Tian, Yulong Shang, Shuoyi Ma, Miao Zhang, Jingyi Liu, (unknown), Lina Cui, (unknown), Ying Han	0
3	Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid 2023 ·Gastroenterología y Hepatología ·(unknown), Pengwei Ren, Guanya Guo, Yansheng Liu, (unknown), (unknown), (unknown), (unknown), (unknown), Xiufang Wang, Xinmin Zhou, Yulong Shang, Ying Han	5
4	Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis 2023 ·Arthritis Research & Therapy ·Siyuan Tian, Yinan Hu, Miao Zhang, (unknown), Guanya Guo, Bo Li, Yulong Shang, Ying Han	5
5	Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC 2023 ·Aging ·(unknown), Guofang Lu, Ying Ma, (unknown), Yulong Shang, Ni Guo, (unknown), (unknown), (unknown)	0
6	Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria 2023 ·Hepatology International ·(unknown), Guanya Guo, Lina Cui, (unknown), Xiufang Wang, Miao Zhang, Siyuan Tian, (unknown), Yansheng Liu, Yinan Hu, (unknown), (unknown), (unknown), (unknown), (unknown), Changcun Guo, Yu Chen, Yulong Shang, Ying Han	8
7	Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial 2022 ·Translational Lung Cancer Research ·Quan Liu, (unknown), (unknown), Meng Chen, Lichun Deng, Jianping Wu, Tong Zhou, Liqin Zhang, Jie Tan, Xingxiang Pu, Yulong Shang, Jun Hua, (unknown), Wei Cai, (unknown), Xingchen Peng, (unknown), Salma K. Jabbour, Hae‐Seong Nam, (unknown)	8
8	Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion 2022 ·Hepatology International ·(unknown), Guanya Guo, Bo Li, (unknown), (unknown), Xiufang Wang, (unknown), (unknown), Xia Zhou, Lina Cui, Changcun Guo, Xinmin Zhou, Patrick S.C. Leung, M. Eric Gershwin, Yulong Shang, Ying Han	15
9	Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma 2021 ·Frontiers in Oncology ·Siyuan Tian, Jingyi Liu, (unknown), Yansheng Liu, Jiahao Yu, Shuoyi Ma, Miao Zhang, (unknown), Xia Zhou, Yulong Shang, Ying Han	5
10	Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma 2020 ·SHILAP Revista de lepidopterología ·Feng Li, Yulong Shang, (unknown), Li Zhang, Jun Yan, Qiang Sun, Jiangfeng She	1
11	NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation 2020 ·Theranostics ·Guofang Lu, Siyuan Tian, Yi Sun, Jiaqiang Dong, Na Wang, (unknown), Yongzhan Nie, Kaichun Wu, Ying Han, Bin Feng, Yulong Shang	35
12	Downregulation of leucine‐rich repeats and immunoglobulin‐like domains 1 by micro RNA ‐20a modulates gastric cancer multidrug resistance 2018 ·Cancer Science ·Lin Zhou, Xiaowei Li, Fan Zhou, (unknown), Di Chen, Pin Wang, Shu Zhang, Yuzheng Zhuge, Yulong Shang, Xiaoping Zou	28
13	miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis 2018 ·Journal of Experimental & Clinical Cancer Research ·Xiaowei Li, Mingzuo Jiang, Di Chen, Bing Xu, Rui Wang, Yi Chu, (unknown), Lin Zhou, (unknown), Yongzhan Nie, Daiming Fan, Yulong Shang, Kaichun Wu, Jie Liang	43
14	O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit 2018 ·Oncogene ·Mingzuo Jiang, Bing Xu, Xiaowei Li, Yulong Shang, Yi Chu, Weijie Wang, Di Chen, Nan Wu, Sijung Hu, Song Zhang, Mengbin Li, Kaichun Wu, Xiaoyong Yang, Jie Liang, Yongzhan Nie, Daiming Fan	113
15	HMGA2–FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer 2017 ·Clinical Cancer Research ·Jiaqiang Dong, Rui Wang, Gui Ren, Xiaowei Li, Jingbo Wang, Yi Sun, Jie Liang, Yongzhan Nie, Kaichun Wu, Bin Feng, Yulong Shang, Daiming Fan	122
16	Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer 2016 ·Autophagy ·Jinfeng Zhou, Jianjun Yang, Xing Fan, Sijung Hu, (unknown), Jiaqiang Dong, Song Zhang, Yulong Shang, Xiaoming Jiang, Hao Guo, Ning Chen, Xiao Xiao, Jianqiu Sheng, Kaichun Wu, Yongzhan Nie, Daiming Fan	77
17	UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation 2015 ·Cancer Biology & Therapy ·Lin Zhou, Yulong Shang, (unknown), Wei Zhang, (unknown), Xiaodi Zhao, Yongqiang Liu, Naiyi Li, Jie Liang	48
18	Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes 2013 ·Tumor Biology ·Yafang Wang, Lili Liu, Xiangqiang Liu, Hui Zhang, Jiaming Liu, Bin Feng, Yulong Shang, Lin Zhou, Kaichun Wu, Yongzhan Nie, Hongbo Zhang, Daiming Fan	18
19	Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance 2013 ·Current Cancer Drug Targets ·Yulong Shang, Xiqiang Cai, Daiming Fan	106
20	Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K 2012 ·Molecular Cancer ·Gui Ren, (unknown), Yanxin An, Bin Feng, Yuanyuan Lu, Jie Liang, Kai Li, Yulong Shang, Yongzhan Nie, Xin Wang, Daiming Fan	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact